KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Other Non-Current Assets (2020 - 2025)

Clover Health Investments' Other Non-Current Assets history spans 6 years, with the latest figure at $24.1 million for Q4 2025.

  • For Q4 2025, Other Non-Current Assets rose 81.9% year-over-year to $24.1 million; the TTM value through Dec 2025 reached $24.1 million, up 81.9%, while the annual FY2025 figure was $24.1 million, 81.9% up from the prior year.
  • Other Non-Current Assets reached $24.1 million in Q4 2025 per CLOV's latest filing, down from $27.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $72.5 million in Q4 2023 to a low of $8.6 million in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $17.2 million, with a median of $14.6 million recorded in 2023.
  • Peak YoY movement for Other Non-Current Assets: skyrocketed 360.57% in 2023, then crashed 81.7% in 2024.
  • A 5-year view of Other Non-Current Assets shows it stood at $10.4 million in 2021, then surged by 50.83% to $15.7 million in 2022, then skyrocketed by 360.57% to $72.5 million in 2023, then plummeted by 81.7% to $13.3 million in 2024, then soared by 81.9% to $24.1 million in 2025.
  • Per Business Quant, the three most recent readings for CLOV's Other Non-Current Assets are $24.1 million (Q4 2025), $27.2 million (Q3 2025), and $15.9 million (Q2 2025).